ArticleSubstance abuse2021
"We'll be able to take care of ourselves" - A qualitative study of client attitudes toward implementing buprenorphine treatment at syringe services programs.
Open access · greenAbstract read
In one paragraph
Article in Substance abuse, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 22 citations in OpenAlex.
- "It was good because they have a relationship with us": A qualitative study on low-threshold buprenorphine treatment at syringe services programs.Journal of substance use and addiction treatment · 2026Trial
- Does perceived stigma impact opioid use disorder treatment uptake? A cross-sectional secondary analysis of buprenorphine engagement among syringe service program participants.Addiction science & clinical practice · 2026Trial
- Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.Harm reduction journal · 2024Trial
- Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation.Harm reduction journal · 2022Trial
- How should low-threshold and primary care clinics prepare to provide long-acting injectable buprenorphine? A qualitative implementation study of patient and staff perspectives.Research square · 2026Article
- Formative Research to Identify Contributors to Risky Drinking and Adapt an Alcohol Reduction Intervention Among Young Adults Vulnerable to HIV: Qualitative Focus Group Study.JMIR formative research · 2026Article
- On-site health service delivery models at syringe services programs in the United States: Results of a national cross-sectional survey.Drug and alcohol dependence reports · 2025Article
- Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study.Annals of medicine · 2023Article
- Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.Addiction science & clinical practice · 2023Article
- Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.Harm reduction journal · 2023Article
- Commentary on Adams et al.: using administrative big data for the public good.Addiction (Abingdon, England) · 2022Article
- Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States.Drug and alcohol dependence · 2022Article
- Vaccination barriers and opportunities at syringe services programs in the United States, June-August 2021-A cross-sectional survey.Drug and alcohol dependence · 2022Article
- Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale.Contemporary clinical trials · 2022Article
- Perceptions and Experiences With Evidence-based Treatments Among People Who Use Opioids.Journal of addiction medicineArticle
- Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes.Journal of addiction medicineArticle
- Cascade of Care for Hepatitis C Virus Infection Among Young Adults Who Inject Drugs in a Rural County in New Mexico.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Taeko FrostWashington Heights CORNER Project, New York, New York, USA.
Sarah DeutschWashington Heights CORNER Project, New York, New York, USA.
Shoshana BrownWashington Heights CORNER Project, New York, New York, USA.
Ellen LemienWashington Heights CORNER Project, New York, New York, USA.
Chinazo O CunninghamDivision of General Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
Aaron D FoxDivision of General Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.ORCID 0000-0002-6904-4795
Neighborhood House · USAlbert Einstein College of Medicine · US
Funding
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Laurie J Bauman · 2017 to 2026
$28.3MImpact of PTSD and trauma reexposure on buprenorphine maintenance treatment in syringe exchange programsR01DA044878 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI FOX, AARON D · 2017 to 2022
$3.7MHIV and Substance Abuse Clinical Addiction Research and Education (CARE) ProgramR25DA023021 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ARNSTEN, JULIA H. · 2007 to 2014
$2.7MBuprenorphine Facilitated Access and Supportive Treatment in Former InmatesK23DA034541 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI FOX, AARON D · 2012 to 2016
$913kMentoring researchers on drug abuse and HIVK24DA036955 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CUNNINGHAM, CHINAZO · 2014 to 2019
$911kDevelopment of a community-based buprenorphine treatment interventionR34DA031066 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CUNNINGHAM, CHINAZO · 2011 to 2013
$709kNIAID NIH HHS P30 AI124414NIDA NIH HHS K23 DA034541NIDA NIH HHS K24 DA036955NIDA NIH HHS R01 DA044878NIDA NIH HHS R25 DA023021NIDA NIH HHS R34 DA031066
Abstract
PubMed holds no abstract for this paper.
Indexed as
BuprenorphineOpioid-Related DisordersAdultAttitudeHarm ReductionHumansQualitative ResearchSyringesBuprenorphineaccess to careBuprenorphineopioid use disordersyringe exchange programs
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.